Balanced news tone
News Sentiment
GRFS sentiment intelligence
Grifols SA ADR news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
54
Balanced news tone
48 relevant articles
News tone and price action are not far from neutral.
78/100 classification confidence.
directly relevant articles
high-authority source matches
+1.5% over one week, -3.6% over four weeks, trend inactive, and near fair-value range.
Grifols stock steadies on its plasma business model
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
78/100 classification
One-week reaction
1.5%
Price digesting
Trend fit
Trend inactive
-3.6% over four weeks
Fair value
-12.8%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
13
Neutral
33
Negative
2
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Insider Monkey
Direct company coverage
Grifols (GRFS) Launches FESILTY in the U.S. for Congenital Fibrinogen Deficiency Treatment
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 16:52
- Source
- Insider Monkey
TradingKey
Direct company coverage
Grifols SA (GRFS) Dividends & Stock Splits: Historical Payouts and Event Timeline
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 13:20
- Source
- TradingKey
MT Newswires
Direct company coverage
Grifols Launches Fesilty Blood Clotting Concentrate in US
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 12:33
- Source
- MT Newswires
GlobeNewswire
Direct company coverage
Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 12:00
- Source
- GlobeNewswire
DirectorsTalk Interviews
Direct company coverage
Grifols, S.A. (GRFS) Stock Analysis: Exploring a 42% Upside Potential in the Healthcare Sector
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 08 Jun 2026 07:00
- Source
- DirectorsTalk Interviews
Seeking Alpha
Direct company coverage
Grifols: Plasma Self-Sufficiency Is The Mispriced Catalyst (NASDAQ:GRFS)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- Seeking Alpha
Market source
Direct company coverage
Grifols, S.A. (GRFS) Sees Strong Biopharma Growth Led by Gamunex and Yimmugo
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- Market source
DirectorsTalk Interviews
Direct company coverage
Grifols, S.A. (GRFS) Stock Analysis: Unveiling a 36% Upside Potential Amidst a Challenging Healthcare Landscape
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- DirectorsTalk Interviews
Market source
Direct company coverage
How The Grifols (BME:GRF) Investment Story Is Shifting With New Analyst Caution
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 23 May 2026 07:00
- Source
- Market source
Investing.com
Direct company coverage
Earnings call transcript: Grifols Q1 2026 sees mixed results with EPS beat
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- Investing.com
Market source
Direct company coverage
Grifols (BME:GRF) Valuation Check After Mixed Short And Long Term Share Price Performance
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 May 2026 07:00
- Source
- Market source
Seeking Alpha
Direct company coverage
Grifols, S.A. 2026 Q1 - Results - Earnings Call Presentation (OTCMKTS:GIKLY) 2026-05-07
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- Seeking Alpha
Market source
Direct company coverage
Grifols (GRFS) Unveils AI-Driven Data for Early Parkinson’s Disease Detection
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Health Canada Imposes New Conditions on Grifols, S.A. (GRFS) Plasma Collection Centers
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Apr 2026 07:00
- Source
- Market source
Seeking Alpha
Direct company coverage
Grifols facing restrictions in Canada after plasma donor deaths
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Apr 2026 07:00
- Source
- Seeking Alpha
Market source
Direct company coverage
Grifols approves IPO of its US biopharma business
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Mar 2026 07:00
- Source
- Market source
Seeking Alpha
Direct company coverage
Grifols: I'm Very Happy To Add In 2026 (NASDAQ:GRFS)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Mar 2026 07:00
- Source
- Seeking Alpha
Quiver Quantitative
Direct company coverage
Grifols S.A. (GRFS) Releases Q4 2025 Earnings: Revenue Up Strongly but EPS and Cash Flow Slump
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 26 Feb 2026 08:00
- Source
- Quiver Quantitative